E. Gottardi

Low-dose imatinib mesylate leads to rapid induction of major molecular responses and achievement of complete molecular remission in FIP1L1-PDGFRA-positive chronic eosinophilic leukemia (2007)

Jovanovic, J.V., Score, J., Waghorn, K., Cilloni, D., Gottardi, E., Metzgeroth, G., ...

The FIP1L1-PDGFRA fusion gene is a recurrent molecular lesion in eosinophilia-associated myeloproliferative disorders, predicting a favorable response to imatinib mesylate. To investigate its...

Quantitative assessment of minimal residual disease in acute myeloid leukemia carrying nucleophosmin (NPM1) gene mutations (2006)

Cazzaniga, G, Alberti, F, Dell'Oro, M G, Gottardi, E, Specchia, G, ...

Mutations in exon 12 of the nucleophosmin (NPM1) gene occur in about 60% of adult AML with normal karyotype. By exploiting a specific feature of NPM1 mutants, that is insertion at residue 956 or...

Low-dose imatinib therapy leads to rapid induction of major molecular responses with achievement of molecular remission in FIP1L1 -PDGFRA associated hypereosinophilic syndrome (2006)

Jovanovic, J., Score, J., Waghorn, K., Reiter, A., Gottardi, E., Saglio, G., ...

Sensitive detection of FIP1L1-PDGFRA fusion transcripts by real-time quantitative RT-PCR (RQ-PCR) reveals achievement of molecular remission in chronic eosinophilic leukemia treated with low-dose imatinib therapy (2005)

Jovanovic, J., Reiter, A., Cilloni, D., Gottardi, E., Score, J., Popp, H., ...

The FIP1L1-PDGFRA fusion gene generated by a cryptic interstitial deletion at 4q12 is a recurrent molecular lesion in idiopathic hypereosinophilic syndrome (HES), that forms a basis for diagnosis of...

Oral sessions. Sensitive detection of FIP1L1-PDGFRA fusion transcripts by real-time quantitative RT-PCR (RQ-PCR) reveals achievement of molecular remission in chronic eosinophilic leukemia treated with low-dose imatinib therapy (2005)

Jovanovic, J., Reiter, A., Cilloni, D., Gottardi, E., Score, J., Popp, H., ...

The FIP1L1-PDGFRA fusion gene generated by a cryptic interstitial deletion at 4q12 is a recurrent molecular lesion in idiopathic hypereosinophilic syndrome (HES), that forms a basis for diagnosis of...

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program (2003)

Beillard, E., Pallisgaard, N., Bi, W., Dee, R., ...

Italian cooperative study on idiopathic hypereosinophilic syndrome (HES): FIP1-L1/PDGFRA rearrangement can be effectively treated with imatinib (2003)

Martinelli, G., Cilloni, D., Ottaviani, E., Malagola, M., Cross, N., Rosti, G., ...

European standardization and quality control program of real time quantitative RT-PCR analysis of fusion gene transcripts for minimal residual disease detection in leukemia patients (2001)

Pradel, V, Aerts, J, Barbany, G, Bi, W, Cave, H, ...

European standardization and quality control program of real the quantitative RT-PCR analysis of fusion gene transcripts for minimal residual disease detection in leukemia patients (2000)

Beillard, E, Bi, W, Pallisgaard, N, Gottardi, E, Cazzaniga, G, ...

Heterozygotes and homozygotes: discrimination by chemical cleavage of mismatch.

Dianzani, I, Forrest, S M, Camaschella, C, Gottardi, E, Cotton, R G

Heterozygotes and homozygotes: discrimination by chemical cleavage of mismatch.

Dianzani, I, Forrest, S M, Camaschella, C, Gottardi, E, Cotton, R G

Systemic activity of inhaled corticosteroid treatment in asthmatic children: corticotrophin releasing hormone test

Pescollderungg, L, Radetti, G, Gottardi, E, Peroni, D, Pietrobelli, A, Boner, A

Background: A study was undertaken to assess the function of the hypothalamic-pituitary-adrenal axis (HPA) in a group of asthmatic children before and after treatment with inhaled corticosteroids.